Kodiak's Zenkuda and tabirafusp-ted hit primary endpoints in Phase 3 DAYBREAK trialSep 28Clinical readoutKodiak Sciences Inc
Kodiak reports Q2 2026 results, confirms three Phase 3 readouts by year-endAug 13Quarterly updateKodiak Sciences Inc
Kodiak Sciences recruiting Phase 3 ALTO trial testing tabirafusp tedromer vs. aflibercept in DMEJul 29Trial updateafliberceptKodiak Sciences Inc
Sign inSign in